Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

7.64
Delayed Data
As of Sep 01
 0.00 / 0.00%
Today’s Change
6.72
Today|||52-Week Range
9.24
+1.87%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close7.64
Today’s openn.a.
Day’s range-- - --
Volume0
Average volume (3 months)22,492
Market cap$73.3M
Dividend yield--
Data as of 09/01/2015

Growth & Valuation

Earnings growth (last year)-26.14%
Earnings growth (this year)-12.16%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+16,502.46%
P/E ratioNM
Price/Sales41.26
Price/Book8.68

Competitors

 Today’s
change
Today’s
% change
CPXXCelator Pharmaceutic...-0.04-1.79%
VCELVericel Corp0.000.00%
OCRXOcera Therapeutics I...+0.07+1.89%
BOTABiota Pharmaceutical...0.000.00%
Data as of 9:41am ET, 09/02/2015

Financials

Next reporting dateNovember 11, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$1.7M
Annual profit (last year)-$10.1M
Net profit margin-609.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Senior Operations Director
Joe Bitterman
Corporate headquarters
San Diego, California

Forecasts

Partner Offers